Cargando…

Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change

Hydrogen formed by small intestinal bacterial overgrowth in patients with non-constipated irritable bowel syndrome has an inverse relationship with obesity. However, the effect of eradicating small intestinal hydrogen-producing bacterial overgrowth on the body weight of these patients has not yet be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Seok-Hoon, Cho, Doo-Yeoun, Joo, Nam-Seok, Kim, Kyu-Nam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940060/ https://www.ncbi.nlm.nih.gov/pubmed/31861004 http://dx.doi.org/10.1097/MD.0000000000018396

Ejemplares similares

Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome
por: Jung, Seung-Eun, et al.
Publicado: (2017)

Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth
por: Chedid, Victor, et al.
Publicado: (2014)

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
por: Boltin, Doron, et al.
Publicado: (2014)

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection
por: Konrad, Paulina, et al.
Publicado: (2018)

Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
por: Gatta, L., et al.
Publicado: (2017)

Is rifaximin better than nonabsorbable disaccharides in hepatic encephalopathy?: A meta-analysis
por: Cheng, Junxiong, et al.
Publicado: (2021)

Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials
por: Li, Jun, et al.
Publicado: (2016)

Probiotics and rifaximin for the prevention of travelers’ diarrhea: A systematic review and network meta-analysis
por: Fan, Hao, et al.
Publicado: (2022)

Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021)

Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms?
por: Tocia, Cristina, et al.
Publicado: (2021)

Serotonin Pathway of Tryptophan Metabolism in Small Intestinal Bacterial Overgrowth—A Pilot Study with Patients Diagnosed with Lactulose Hydrogen Breath Test and Treated with Rifaximin
por: Chojnacki, Cezary, et al.
Publicado: (2021)

Signet ring cell carcinoma of early gastric cancer, is endoscopic treatment really risky?
por: Kang, Sun Hyung, et al.
Publicado: (2017)

Predictor of abnormal gallbladder ejection fraction in patients with atypical biliary pain: Histopathological point of view
por: Lim, Jun Uk, et al.
Publicado: (2017)

Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

Risk factors for the histologic discrepancy of gastric adenomatous lesions and long-term outcome
por: Joo, Jong Seok, et al.
Publicado: (2021)

The antioncogenic effect of Beclin-1 and FOXP3 is associated with SKP2 expression in gastric adenocarcinoma
por: Kim, Hyung Kyung, et al.
Publicado: (2021)

Feasibility of using two-dimensional axial computed tomography in pretreatment decision making for patients with early gastric cancer
por: Kim, Duk Ki, et al.
Publicado: (2020)

Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis
por: Kim, Jung Ho, et al.
Publicado: (2016)

Predictors of clinical outcomes of self-expandable metal stent treatment for malignant colorectal obstruction: A Honam Association for the Study of Intestinal Disease (HASID) multicenter study
por: Han, Bora, et al.
Publicado: (2021)

Clinical outcome after endoscopic submucosal dissection for early gastric cancer of absolute and expanded indication
por: Kim, Ju Seok, et al.
Publicado: (2017)

Efficacy of complementary medicine for nonsteroidal anti-inflammatory drug-induced small intestinal injuries: A narrative review
por: Cho, Minji, et al.
Publicado: (2021)

The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis
por: Kuang, Sheng, et al.
Publicado: (2021)

Heart rate variability and inflammatory bowel disease in humans: A systematic review and meta-analysis
por: Kim, Kyu-Nam, et al.
Publicado: (2020)

Immunoglobulin G4-related disease in the stomach presenting as a gastric subepithelial tumor: Case report
por: Cho, Min Ji, et al.
Publicado: (2020)

The incidence and risk factors of sessile serrated adenomas in left side colon cancer patients after curative surgery
por: Kim, Myung Hee, et al.
Publicado: (2020)

Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report
por: Park, Dae Hwa, et al.
Publicado: (2017)

Comparison and validation of the Japanese score and other scoring systems in patients with peptic ulcer bleeding: A retrospective study
por: Kim, Seong Hoon, et al.
Publicado: (2023)

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016)

Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma: Is it a significant prognostic factor?
por: Shin, Hae Jin, et al.
Publicado: (2017)

Self-expandable metal stent of esophagogastric junction versus pyloric area obstruction in advanced gastric cancer patients: Retrospective, comparative, single-center study
por: Kim, Deok Yeong, et al.
Publicado: (2020)

Diet and intestinal bacterial overgrowth: Is there evidence?
por: Souza, Claudineia, et al.
Publicado: (2022)

Epidemiology of small intestinal bacterial overgrowth
por: Efremova, Irina, et al.
Publicado: (2023)

Probiotics for Standard Triple Helicobacter pylori Eradication: A Randomized, Double-blind, Placebo-controlled Trial
por: Hauser, Goran, et al.
Publicado: (2015)

Comparing large-volume band ligators and cyanoacrylate injection for gastric variceal eradication: A prospective study
por: Shi, Ding, et al.
Publicado: (2022)

Combined effect of serum alanine aminotransferase and gamma-glutamyltransferase on incidence of diabetes mellitus: A longitudinal study
por: Choi, Sung-Hyun, et al.
Publicado: (2020)

Risk Factors of Submucosal or Lymphovascular Invasion in Early Gastric Cancer <2 cm
por: Choi, Yu Yi, et al.
Publicado: (2016)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial
por: Zhang, Di, et al.
Publicado: (2017)

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

Efficacy of Helicobacter pylori eradication therapy for treatment of functional dyspepsia: A protocol for systematic review and meta-analysis
por: Wang, Jue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_23evi038pvaei5ejdhn9up3stt